Piperidine derivatives as inhibitors of nicotinamide N-methyltransferase.

CO20260011436A2Pending Publication Date: 2026-08-31ASTRAZENECA AB
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CO20260011436
Authority / Receiving Office
CO · CO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-01-10
Filing Date
2026-08-12
Publication Date
2026-08-31
Patent Text Reader

Abstract

Certain piperidine derivatives of Formula (I), and pharmaceutically acceptable salts thereof, are described, along with compositions containing them and their use in therapy. These compounds are inhibitors of nicotinamide N-methyltransferase (NNMT) and are thus particularly useful in the treatment or prophylaxis of, for example, chronic kidney disease, acute kidney injury, or heart failure.
Need to check novelty before this filing date? Find Prior Art